173 related articles for article (PubMed ID: 37692082)
1. Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer.
Liu Y; Liang Y; Li Q; Li Q
Comput Struct Biotechnol J; 2023; 21():4238-4251. PubMed ID: 37692082
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer.
Seneviratne C; Shetty AC; Geng X; McCracken C; Cornell J; Mullins K; Jiang F; Stass S
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552904
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.
Ning C; Cai P; Liu X; Li G; Bao P; Yan L; Ning M; Tang K; Luo Y; Guo H; Wang Y; Wang Z; Chen L; Lu ZJ; Yin J
EBioMedicine; 2023 Jul; 93():104645. PubMed ID: 37315449
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Siveke JT; Schuler M; Lueong SS
Thorac Cancer; 2022 Aug; 13(15):2180-2191. PubMed ID: 35708207
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
[TBL] [Abstract][Full Text] [Related]
7. Method for the extraction of circulating nucleic acids based on MOF reveals cell-free RNA signatures in liver cancer.
Sun Y; Yu H; Han S; Ran R; Yang Y; Tang Y; Wang Y; Zhang W; Tang H; Fu B; Fu B; Weng X; Liu SM; Deng H; Peng S; Zhou X
Natl Sci Rev; 2024 Jan; 11(1):nwae022. PubMed ID: 38348130
[TBL] [Abstract][Full Text] [Related]
8. Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification.
Wang J; Huang J; Hu Y; Guo Q; Zhang S; Tian J; Niu Y; Ji L; Xu Y; Tang P; He Y; Wang Y; Zhang S; Yang H; Kang K; Chen X; Li X; Yang M; Gou D
Nat Commun; 2024 Jan; 15(1):156. PubMed ID: 38168054
[TBL] [Abstract][Full Text] [Related]
9. Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer.
Safrastyan A; Zu Siederdissen CH; Wollny D
Hum Genomics; 2023 Oct; 17(1):90. PubMed ID: 37798661
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases.
Li Y; Polyak D; Lamsam L; Connolly ID; Johnson E; Khoeur LK; Andersen S; Granucci M; Stanley G; Liu B; Nagpal S; Hayden Gephart M
NPJ Precis Oncol; 2021 Oct; 5(1):90. PubMed ID: 34625644
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Effects of Storage Conditions on Multiple Cell-Free RNAs in Plasma by High-Throughput Sequencing.
Sun J; Yang X; Wang T; Xing Y; Chen H; Zhu S; Zeng J; Zhou Q; Chen F; Zhang X; Wang WJ
Biopreserv Biobank; 2023 Jun; 21(3):242-254. PubMed ID: 36006659
[No Abstract] [Full Text] [Related]
13. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
[TBL] [Abstract][Full Text] [Related]
14. Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer.
Jin N; Kan CM; Pei XM; Cheung WL; Ng SSM; Wong HT; Cheng HY; Leung WW; Wong YN; Tsang HF; Chan AKC; Wong YKE; Cho WCS; Chan JKC; Tai WCS; Chan TF; Wong SCC; Yim AK; Yu AC
Front Oncol; 2023; 13():1134445. PubMed ID: 37091184
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell-free RNA Signatures of Inflammatory Syndromes in Children.
Loy CJ; Servellita V; Sotomayor-Gonzalez A; Bliss A; Lenz J; Belcher E; Suslovic W; Nguyen J; Williams ME; Oseguera M; Gardiner MA; ; ; Choi JH; Hsiao HM; Wang H; Kim J; Shimizu C; Tremoulet A; Delaney M; DeBiasi RL; Rostad CA; Burns JC; Chiu CY; Vlaminck I
medRxiv; 2024 Mar; ():. PubMed ID: 38496479
[TBL] [Abstract][Full Text] [Related]
16. Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patients.
Mullins KE; Seneviratne C; Shetty AC; Jiang F; Christenson R; Stass S
Clin Biochem; 2023 Aug; 118():110583. PubMed ID: 37182637
[TBL] [Abstract][Full Text] [Related]
17. The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery.
Wang Z; Ou Q; Gao L
Front Immunol; 2023; 14():1154025. PubMed ID: 37275889
[TBL] [Abstract][Full Text] [Related]
18. Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Metzenmacher M; Váraljai R; Hegedüs B; Cima I; Forster J; Schramm A; Scheffler B; Horn PA; Klein CA; Szarvas T; Reis H; Bielefeld N; Roesch A; Aigner C; Kunzmann V; Wiesweg M; Siveke JT; Schuler M; Lueong SS
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033141
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing.
Pan W; Ngo TTM; Camunas-Soler J; Song CX; Kowarsky M; Blumenfeld YJ; Wong RJ; Shaw GM; Stevenson DK; Quake SR
Clin Chem; 2017 Nov; 63(11):1695-1704. PubMed ID: 28904056
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
